Lyell Immunopharma, Inc.
NASDAQ:LYELBiotechnology
Healthcare
$13.67 +1.20%
+$0.15 today
- Market cap
- $336.08M
- Beta
- -0.09
- P/E (TTM)
- -1.1
- EPS (TTM)
- -$11.26
52W Low $8.46High $45.00
Volume 0.18M
Average 0.09M
Price history
Lyell Immunopharma, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-23.76%
Period high
$38.60
Period low
$7.51
Latest
$13.67
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| S-3 | Nov 13, 2026 | Nov 13, 2026 | |
| 4 | Nov 12, 2026 | Nov 12, 2026 | |
| 4 | Nov 12, 2026 | Nov 12, 2026 | |
| 4 | Nov 12, 2026 | Nov 12, 2026 | |
| 4 | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G/A | Nov 10, 2026 | Nov 10, 2026 | |
| 4 | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 4, 2026 | Nov 4, 2026 | |
| 8-K | Nov 4, 2026 | Nov 4, 2026 | |
| 8-K | Nov 4, 2026 | Nov 4, 2026 | |
| 4 | Oct 13, 2026 | Oct 13, 2026 | |
| 3 | Sep 10, 2026 | Sep 10, 2026 | |
| 4 | Sep 10, 2026 | Sep 10, 2026 | |
| 8-K | Sep 10, 2026 | Sep 10, 2026 |
Competitors
Who does Lyell Immunopharma, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about LYEL's filings, answered from its disclosures.
What is the latest LYEL filing?
The latest filing shown is S-3 dated Nov 13, 2026.
How many recent filings does LYEL have?
Intrinsic Alpha currently shows 20 recent filings for LYEL.
Continue the stock analysis
Jump to another research area for this company.